skip to Main Content

Appendix 169: NWO = Eugenics + Transhumanism; w/ Related DARPA Reports On Brain-Machine Interface Tech (Whitney Webb Interview, Jan. 22, 2023)

On Globalist Technocrat Links To Nazis, Organised Crime, Eugenics & Transhumanism

Some DARPA Documents Referenced in Video:

Six Paths to the Nonsurgical Future of Brain-Machine Interfaces

Teams selected for DARPA’s Next-Generation Nonsurgical Neurotechnology program will pursue a mix of approaches to developing wearable interfaces for communicating with the brain
Next-Generation Nonsurgical Neurotechnology (N3)

DARPA has awarded funding to six organizations to support the Next-Generation Nonsurgical Neurotechnology (N3) program, first announced in March 2018. Battelle Memorial Institute, Carnegie Mellon University, Johns Hopkins University Applied Physics Laboratory, Palo Alto Research Center (PARC), Rice University, and Teledyne Scientific are leading multidisciplinary teams to develop high-resolution, bidirectional brain-machine interfaces for use by able-bodied service members. These wearable interfaces could ultimately enable diverse national security applications such as control of active cyber defense systems and swarms of unmanned aerial vehicles, or teaming with computer systems to multitask during complex missions.

“DARPA is preparing for a future in which a combination of unmanned systems, artificial intelligence, and cyber operations may cause conflicts to play out on timelines that are too short for humans to effectively manage with current technology alone,” said Al Emondi, the N3 program manager. “By creating a more accessible brain-machine interface that doesn’t require surgery to use, DARPA could deliver tools that allow mission commanders to remain meaningfully involved in dynamic operations that unfold at rapid speed.”

Over the past 18 years, DARPA has demonstrated increasingly sophisticated neurotechnologies that rely on surgically implanted electrodes to interface with the central or peripheral nervous systems. The agency has demonstrated achievements such as neural control of prosthetic limbs and restoration of the sense of touch to the users of those limbs, relief of otherwise intractable neuropsychiatric illnesses such as depression, and improvement of memory formation and recall. Due to the inherent risks of surgery, these technologies have so far been limited to use by volunteers with clinical need.

For the military’s primarily able-bodied population to benefit from neurotechnology, nonsurgical interfaces are required. Yet, in fact, similar technology could greatly benefit clinical populations as well. By removing the need for surgery, N3 systems seek to expand the pool of patients who can access treatments such as deep brain stimulation to manage neurological illnesses.

The N3 teams are pursuing a range of approaches that use optics, acoustics, and electromagnetics to record neural activity and/or send signals back to the brain at high speed and resolution. The research is split between two tracks. Teams are pursuing either completely noninvasive interfaces that are entirely external to the body or minutely invasive interface systems that include nanotransducers that can be temporarily and nonsurgically delivered to the brain to improve signal resolution.

  • The Battelle team, under principal investigator Dr. Gaurav Sharma, aims to develop a minutely invasive interface system that pairs an external transceiver with electromagnetic nanotransducers that are nonsurgically delivered to neurons of interest. The nanotransducers would convert electrical signals from the neurons into magnetic signals that can be recorded and processed by the external transceiver, and vice versa, to enable bidirectional communication.
  • The Carnegie Mellon University team, under principal investigator Dr. Pulkit Grover, aims to develop a completely noninvasive device that uses an acousto-optical approach to record from the brain and interfering electrical fields to write to specific neurons. The team will use ultrasound waves to guide light into and out of the brain to detect neural activity. The team’s write approach exploits the non-linear response of neurons to electric fields to enable localized stimulation of specific cell types.
  • The Johns Hopkins University Applied Physics Laboratory team, under principal investigator Dr. David Blodgett, aims to develop a completely noninvasive, coherent optical system for recording from the brain. The system will directly measure optical path-length changes in neural tissue that correlate with neural activity.
  • The PARC team, under principal investigator Dr. Krishnan Thyagarajan, aims to develop a completely noninvasive acousto-magnetic device for writing to the brain. Their approach pairs ultrasound waves with magnetic fields to generate localized electric currents for neuromodulation. The hybrid approach offers the potential for localized neuromodulation deeper in the brain.
  • The Rice University team, under principal investigator Dr. Jacob Robinson, aims to develop a minutely invasive, bidirectional system for recording from and writing to the brain. For the recording function, the interface will use diffuse optical tomography to infer neural activity by measuring light scattering in neural tissue. To enable the write function, the team will use a magneto-genetic approach to make neurons sensitive to magnetic fields.
  • The Teledyne team, under principal investigator Dr. Patrick Connolly, aims to develop a completely noninvasive, integrated device that uses micro optically pumped magnetometers to detect small, localized magnetic fields that correlate with neural activity. The team will use focused ultrasound for writing to neurons.

Throughout the program, the research will benefit from insights provided by independent legal and ethical experts who have agreed to provide insights on N3 progress and consider potential future military and civilian applications and implications of the technology. Additionally, federal regulators are cooperating with DARPA to help the teams better understand human-use clearance as research gets underway. As the work progresses, these regulators will help guide strategies for submitting applications for Investigational Device Exemptions and Investigational New Drugs to enable human trials of N3 systems during the last phase of the four-year program.

“If N3 is successful, we’ll end up with wearable neural interface systems that can communicate with the brain from a range of just a few millimeters, moving neurotechnology beyond the clinic and into practical use for national security,” Emondi said. “Just as service members put on protective and tactical gear in preparation for a mission, in the future they might put on a headset containing a neural interface, use the technology however it’s needed, then put the tool aside when the mission is complete.”

Additional details of the program schedule and metrics are available in the 2018 broad agency announcement:

II. DARPA’s Next-Generation Non-Surgical Neurotechnology (N3) 2018 (pdf)

III. Reliable Neural-Interface Technology (RE-NET) (Archived)

Reliable Neural-Interface Technology (RE-NET) (Archived)

Improved technology for military uniforms, body armor, and equipment saves the lives of thousands of Service members injured on the battlefield. Unfortunately, many of those survivors come home seriously and permanently wounded, suffering unprecedented rates of limb loss and traumatic brain injury. This crisis has motivated great interest in the science of and technology for restoring sensorimotor functions lost to amputation and injury to the central nervous system. For more than a decade, DARPA has led efforts aimed at revolutionizing the state of the art in prosthetic limbs, yielding two advanced mechatronic limbs for the upper extremity. These new devices are truly anthropomorphic and capable of performing dexterous manipulation functions that finally begin to approach the capabilities of natural limbs. However, in the absence of a high-bandwidth, intuitive control interface for these limbs, they will not achieve their full potential to improve quality of life for wounded troops.

DARPA launched the Reliable Neural-Interface Technology (RE-NET) program in 2010 to directly address the need for high-performance neural interfaces to control the dexterous functions made possible by DARPA’s advanced prosthetic limbs. Specifically, RE-NET seeks to develop the technologies needed to reliably extract information from the nervous system, and do so at the scale and rate necessary to control many degree-of-freedom machines. Prior to RE-NET, all existing methods to extract neural-control signals were inadequate for amputees to control high-performance prostheses, either because the level of extracted information was too low or the functional lifetime of the interface was too short.

Ongoing technological advances create new opportunities to solve both of these traditional problems with neural interfaces. For example, it is now feasible to develop high-resolution peripheral neuromuscular interfaces that increase the amount of information obtained from the peripheral nervous system. Furthermore, advances in cortical microelectrode technologies are extending the durability of neural signals obtained from the brain, making it possible to create brain-controlled prosthetics that remain useful over the lifetime of the patient.

The RE-NET program is divided into three complementary efforts aimed at understanding why the performance of neural interfaces degrades over time and developing new high-performance neural interfaces that last the life of the patient.

Ultimately, DARPA seeks to develop clinically viable technologies that provide neural control of state-of-the-art prosthetic limbs to amputees and people with spinal cord injuries and neurological diseases that restrict movement.


This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top